Clinical Trials Browser

Phase 2 × Triple Negative Breast Neoplasms × avelumab × Clear all

NCT03971409 2025-05-02

InCITe

Phase 2 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03554109 2025-02-21

TNBC

Phase 2 Withdrawn

Triple Negative Breast Neoplasms